QUALIGEN THERAPEUTICS, INC. - Common Stock, par value $0.001 per share (QLGN)

CUSIP: 74754R103

Q1 2021 13F Holders as of 31 Mar 2021

Holder snapshot 7 signals
Share change
+645,564
Put/Call ratio
1095%
SEC-reported price per share
$2.70
Number of holders
28
Value change
+$1,699,282
Number of buys
16
Open additional details 1 more signal available
Number of sells
8
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
6,138,804

Security key

74754R103

Report period

Q1 2021

Institutions

28

Top holders

10

Ownership snapshot

Top reported holders of QLGN - QUALIGEN THERAPEUTICS, INC. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
BlackRock Finance, Inc.
Disclosed value leader
BlackRock Finance, Inc.
Comparable rows
15/15
Latest evidence
31 Dec 2020
13F Lead comparable stake: 5.2% Showing 1-6 of 15 holder rows.

Quick read

BlackRock Finance, Inc. leads the comparable SEC ownership view at 5.2%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens BlackRock Finance, Inc.'s linked filing trail.
Comparable ownership Top 5
BlackRock Finance, Inc. 5.2%
VANGUARD GROUP INC 4.9%
GEODE CAPITAL MANAGEMENT, LLC 2%
QS Investors, LLC 1.3%
SUSQUEHANNA FUNDAMENTAL INVESTMEN... 1%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
BlackRock Finance, Inc.
13F
Company
13F
5.2%
$957,000
317,818 shares
31 Dec 2020
VANGUARD GROUP INC
13F
Company
13F
4.9%
$907,000
301,195 shares
31 Dec 2020
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
13F
2%
$370,000
123,035 shares
31 Dec 2020
QS Investors, LLC
13F
Company
13F
1.3%
$247,000
82,000 shares
31 Dec 2020
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC
13F
Company
13F
1%
$188,000
62,500 shares
31 Dec 2020
CITADEL ADVISORS LLC
13F
Company
13F
0.75%
$138,000
45,928 shares
31 Dec 2020
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2021

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
28
Shares
1,892,924
Rows available
28
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2021 vs Q4 2020 Across Filers

Q4 2020 holders
25
Q1 2021 holders
28
Holder diff
3
Investor Q4 2020 Shares Q1 2021 Shares Share Diff Share Chg % Q4 2020 value Q1 2021 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .